4//SEC Filing
King-Jones Heidy 4
Accession 0001493152-21-011581
CIK 0001695357other
Filed
May 13, 8:00 PM ET
Accepted
May 14, 7:41 PM ET
Size
5.9 KB
Accession
0001493152-21-011581
Insider Transaction Report
Form 4
King-Jones Heidy
Chief Legal Officer
Transactions
- Award
Stock Option (right to buy)
2021-05-12+139,500→ 139,500 totalExercise: $6.80Exp: 2031-05-12→ Common Stock, par value $0.0001 (139,500 underlying)
Footnotes (2)
- [F1]69,750 of the options granted will vest as follows: 25% will vest and become exercisable on May 12, 2022 and 75% will vest and become exercisable monthly over 36 months such that these options will be fully vested and exercisable on May 12, 2025. The remaining 69,750 of the options granted will vest and become exercisable, if at all, in three equal installments of 23,250 options, with each such installment triggered upon the achievement of one of three separate corporate performance milestones prior to or during the year 2024.
- [F2]The securities were granted pursuant to the Issuer's Amended and Restated 2017 Equity Incentive Plan.
Documents
Issuer
Provention Bio, Inc.
CIK 0001695357
Entity typeother
Related Parties
1- filerCIK 0001794898
Filing Metadata
- Form type
- 4
- Filed
- May 13, 8:00 PM ET
- Accepted
- May 14, 7:41 PM ET
- Size
- 5.9 KB